TEVA logo

TEVA Gross profit

Annual gross profit:

$8.06B+$419.00M(+5.48%)
December 31, 2024

Summary

  • As of today (September 17, 2025), TEVA annual gross profit is $8.06 billion, with the most recent change of +$419.00 million (+5.48%) on December 31, 2024.
  • During the last 3 years, TEVA annual gross profit has risen by +$470.00 million (+6.19%).
  • TEVA annual gross profit is now -30.80% below its all-time high of $11.65 billion, reached on December 31, 2016.

Performance

TEVA Gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAincome statement metrics

quarterly gross profit:

$2.18B+$328.45M(+17.75%)
June 30, 2025

Summary

  • As of today (September 17, 2025), TEVA quarterly gross profit is $2.18 billion, with the most recent change of +$328.45 million (+17.75%) on June 30, 2025.
  • Over the past year, TEVA quarterly gross profit has increased by +$156.45 million (+7.74%).
  • TEVA quarterly gross profit is now -35.74% below its all-time high of $3.39 billion, reached on December 31, 2016.

Performance

TEVA quarterly gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAincome statement metrics

TTM gross profit:

$8.27B+$156.45M(+1.93%)
June 30, 2025

Summary

  • As of today (September 17, 2025), TEVA TTM gross profit is $8.27 billion, with the most recent change of +$156.45 million (+1.93%) on June 30, 2025.
  • Over the past year, TEVA TTM gross profit has increased by +$200.45 million (+2.48%).
  • TEVA TTM gross profit is now -30.52% below its all-time high of $11.91 billion, reached on March 31, 2017.

Performance

TEVA TTM gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAincome statement metrics

Gross profit Formula

Gross Profit = Revenue − Cost Of Goods Sold

TEVA Gross profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+5.5%+7.7%+2.5%
3 y3 years+6.2%+22.9%+14.1%
5 y5 years+7.0%+25.0%+10.0%

TEVA Gross profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+15.7%-10.7%+38.2%-1.5%+21.4%
5 y5-yearat high+15.7%-10.7%+38.2%-1.5%+21.4%
alltimeall time-30.8%>+9999.0%-35.7%>+9999.0%-30.5%>+9999.0%

TEVA Gross profit History

DateAnnualQuarterlyTTM
Jun 2025
-
$2.18B(+17.8%)
$8.27B(+1.9%)
Mar 2025
-
$1.85B(-11.4%)
$8.12B(+0.8%)
Dec 2024
$8.06B(+5.5%)
$2.09B(-3.3%)
$8.05B(-4.2%)
Sep 2024
-
$2.16B(+6.7%)
$8.40B(+4.1%)
Jun 2024
-
$2.02B(+13.3%)
$8.07B(+2.8%)
Mar 2024
-
$1.78B(-26.8%)
$7.85B(+2.7%)
Dec 2023
$7.64B(+9.6%)
$2.44B(+33.3%)
$7.64B(+8.7%)
Sep 2023
-
$1.83B(+1.6%)
$7.03B(+2.8%)
Jun 2023
-
$1.80B(+14.2%)
$6.84B(+0.4%)
Mar 2023
-
$1.58B(-13.8%)
$6.81B(-1.8%)
Dec 2022
$6.97B(-8.2%)
$1.83B(+11.9%)
$6.94B(-2.7%)
Sep 2022
-
$1.64B(-7.8%)
$7.13B(-1.6%)
Jun 2022
-
$1.77B(+4.4%)
$7.25B(-1.6%)
Mar 2022
-
$1.70B(-16.1%)
$7.37B(-1.7%)
Dec 2021
$7.59B(-1.7%)
$2.02B(+15.5%)
$7.49B(-0.3%)
Sep 2021
-
$1.75B(-7.1%)
$7.51B(-1.3%)
Jun 2021
-
$1.89B(+3.6%)
$7.61B(+1.9%)
Mar 2021
-
$1.82B(-11.0%)
$7.47B(-2.4%)
Dec 2020
$7.73B(+2.5%)
$2.05B(+10.5%)
$7.65B(+1.4%)
Sep 2020
-
$1.85B(+6.4%)
$7.55B(+0.4%)
Jun 2020
-
$1.74B(-13.2%)
$7.52B(-2.0%)
Mar 2020
-
$2.01B(+3.3%)
$7.67B(+2.0%)
Dec 2019
$7.54B(-9.1%)
$1.94B(+6.5%)
$7.52B(-0.4%)
Sep 2019
-
$1.82B(-3.6%)
$7.54B(-2.5%)
Jun 2019
-
$1.89B(+2.0%)
$7.74B(-1.8%)
Mar 2019
-
$1.86B(-5.8%)
$7.88B(-5.5%)
Dec 2018
$8.30B(-21.8%)
$1.97B(-2.5%)
$8.34B(-3.5%)
Sep 2018
-
$2.02B(-0.6%)
$8.64B(-6.8%)
Jun 2018
-
$2.03B(-12.2%)
$9.27B(-8.1%)
Mar 2018
-
$2.31B(+1.9%)
$10.09B(-4.9%)
Dec 2017
$10.62B(-8.9%)
$2.27B(-14.3%)
$10.62B(-9.5%)
Sep 2017
-
$2.65B(-7.2%)
$11.73B(-1.3%)
Jun 2017
-
$2.85B(+0.6%)
$11.88B(-0.2%)
Mar 2017
-
$2.84B(-16.3%)
$11.91B(+0.4%)
Dec 2016
$11.65B(+2.6%)
$3.39B(+21.0%)
$11.86B(+4.8%)
Sep 2016
-
$2.80B(-2.6%)
$11.32B(+0.3%)
Jun 2016
-
$2.88B(+3.1%)
$11.28B(-0.1%)
Mar 2016
-
$2.79B(-2.0%)
$11.29B(-0.3%)
Dec 2015
$11.36B(+2.7%)
$2.85B(+2.9%)
$11.33B(-0.3%)
Sep 2015
-
$2.77B(-4.1%)
$11.36B(-0.4%)
Jun 2015
-
$2.89B(+2.2%)
$11.41B(+2.0%)
Mar 2015
-
$2.83B(-2.0%)
$11.18B(+1.1%)
Dec 2014
$11.06B(+3.3%)
$2.88B(+2.6%)
$11.05B(-0.7%)
Sep 2014
-
$2.81B(+5.6%)
$11.13B(+0.9%)
Jun 2014
-
$2.66B(-1.4%)
$11.03B(-0.4%)
Mar 2014
-
$2.70B(-8.9%)
$11.07B(+0.3%)
Dec 2013
$10.71B(+0.5%)
$2.96B(+9.4%)
$11.04B(+1.7%)
Sep 2013
-
$2.71B(+0.2%)
$10.86B(+2.0%)
Jun 2013
-
$2.70B(+1.2%)
$10.65B(+1.1%)
Mar 2013
-
$2.67B(-4.1%)
$10.54B(+1.7%)
Dec 2012
$10.65B(+11.9%)
$2.78B(+11.5%)
$10.36B(+0.3%)
Sep 2012
-
$2.50B(-3.5%)
$10.33B(+2.6%)
Jun 2012
-
$2.59B(+3.6%)
$10.06B(+3.1%)
Mar 2012
-
$2.49B(-9.4%)
$9.76B(+2.7%)
Dec 2011
$9.52B(+5.0%)
$2.75B(+23.4%)
$9.51B(+3.1%)
Sep 2011
-
$2.23B(-2.4%)
$9.22B(-2.1%)
Jun 2011
-
$2.29B(+2.2%)
$9.42B(+1.6%)
Mar 2011
-
$2.24B(-9.2%)
$9.27B(+2.5%)
Dec 2010
$9.06B
$2.46B(+1.2%)
$9.05B(+3.6%)
DateAnnualQuarterlyTTM
Sep 2010
-
$2.43B(+13.6%)
$8.73B(+6.4%)
Jun 2010
-
$2.14B(+6.5%)
$8.21B(+5.1%)
Mar 2010
-
$2.01B(-6.4%)
$7.81B(+5.6%)
Dec 2009
$7.37B(+23.4%)
$2.15B(+12.6%)
$7.40B(+7.8%)
Sep 2009
-
$1.91B(+9.6%)
$6.86B(+6.3%)
Jun 2009
-
$1.74B(+8.7%)
$6.46B(+4.4%)
Mar 2009
-
$1.60B(-0.7%)
$6.19B(+4.0%)
Dec 2008
$5.97B(+22.4%)
$1.61B(+7.2%)
$5.95B(+3.3%)
Sep 2008
-
$1.50B(+2.3%)
$5.76B(+4.7%)
Jun 2008
-
$1.47B(+7.8%)
$5.50B(+3.5%)
Mar 2008
-
$1.36B(-4.2%)
$5.32B(+6.6%)
Dec 2007
$4.88B(+14.5%)
$1.42B(+14.1%)
$4.99B(+6.9%)
Sep 2007
-
$1.25B(-3.0%)
$4.67B(-0.1%)
Jun 2007
-
$1.29B(+24.2%)
$4.67B(+2.7%)
Mar 2007
-
$1.04B(-5.7%)
$4.55B(+7.3%)
Dec 2006
$4.26B(+71.7%)
$1.10B(-12.3%)
$4.24B(+11.7%)
Sep 2006
-
$1.25B(+7.5%)
$3.80B(+20.6%)
Jun 2006
-
$1.16B(+60.7%)
$3.15B(+22.6%)
Mar 2006
-
$724.61M(+10.6%)
$2.57B(+4.4%)
Dec 2005
$2.48B(+10.8%)
$654.97M(+8.3%)
$2.46B(+1.1%)
Sep 2005
-
$604.80M(+3.6%)
$2.43B(+0.7%)
Jun 2005
-
$583.69M(-5.3%)
$2.42B(+1.6%)
Mar 2005
-
$616.11M(-1.8%)
$2.38B(+6.1%)
Dec 2004
$2.24B(+47.4%)
$627.47M(+6.6%)
$2.24B(+9.1%)
Sep 2004
-
$588.60M(+8.0%)
$2.05B(+10.7%)
Jun 2004
-
$544.99M(+13.7%)
$1.86B(+10.1%)
Mar 2004
-
$479.32M(+8.8%)
$1.68B(+8.7%)
Dec 2003
$1.52B(+38.7%)
$440.39M(+12.7%)
$1.55B(+6.9%)
Sep 2003
-
$390.91M(+4.5%)
$1.45B(+9.5%)
Jun 2003
-
$374.16M(+8.6%)
$1.32B(+12.3%)
Mar 2003
-
$344.58M(+1.2%)
$1.18B(+9.9%)
Dec 2002
$1.10B(+29.3%)
$340.41M(+28.1%)
$1.07B(+10.3%)
Sep 2002
-
$265.64M(+16.1%)
$972.91M(+7.1%)
Jun 2002
-
$228.80M(-4.1%)
$908.80M(+3.0%)
Mar 2002
-
$238.50M(-0.6%)
$882.33M(+5.2%)
Dec 2001
$847.29M(+7.7%)
$239.97M(+19.1%)
$838.89M(+40.1%)
Sep 2001
-
$201.53M(-0.4%)
$598.92M(+50.7%)
Jun 2001
-
$202.32M(+3.7%)
$397.38M(+103.7%)
Mar 2001
-
$195.06M(>+9900.0%)
$195.06M(>+9900.0%)
Dec 2000
$786.86M(+34.9%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2000
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2000
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2000
-
$0.00(0.0%)
$0.00(0.0%)
Dec 1999
$583.20M(+21.5%)
-
-
Dec 1998
$479.83M(-1.7%)
-
-
Sep 1998
-
$0.00(0.0%)
$0.00(0.0%)
Jun 1998
-
$0.00(0.0%)
$0.00(0.0%)
Mar 1998
-
$0.00
$0.00
Dec 1997
$488.00M(+21.0%)
-
-
Dec 1996
$403.40M(+22.3%)
-
-
Dec 1995
$329.80M(+5.7%)
-
-
Dec 1994
$312.10M(+33.7%)
-
-
Dec 1993
$233.50M(+35.4%)
-
-
Dec 1992
$172.50M(+29.7%)
-
-
Dec 1991
$133.00M(-3.4%)
-
-
Dec 1990
$137.70M(+37.2%)
-
-
Dec 1989
$100.40M(+23.0%)
-
-
Dec 1988
$81.60M(+49.2%)
-
-
Mar 1987
$54.70M(+68.8%)
-
-
Mar 1986
$32.40M
-
-

FAQ

  • What is Teva Pharmaceutical Industries Limited annual gross profit?
  • What is the all time high annual gross profit for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited annual gross profit year-on-year change?
  • What is Teva Pharmaceutical Industries Limited quarterly gross profit?
  • What is the all time high quarterly gross profit for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited quarterly gross profit year-on-year change?
  • What is Teva Pharmaceutical Industries Limited TTM gross profit?
  • What is the all time high TTM gross profit for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited TTM gross profit year-on-year change?

What is Teva Pharmaceutical Industries Limited annual gross profit?

The current annual gross profit of TEVA is $8.06B

What is the all time high annual gross profit for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high annual gross profit is $11.65B

What is Teva Pharmaceutical Industries Limited annual gross profit year-on-year change?

Over the past year, TEVA annual gross profit has changed by +$419.00M (+5.48%)

What is Teva Pharmaceutical Industries Limited quarterly gross profit?

The current quarterly gross profit of TEVA is $2.18B

What is the all time high quarterly gross profit for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high quarterly gross profit is $3.39B

What is Teva Pharmaceutical Industries Limited quarterly gross profit year-on-year change?

Over the past year, TEVA quarterly gross profit has changed by +$156.45M (+7.74%)

What is Teva Pharmaceutical Industries Limited TTM gross profit?

The current TTM gross profit of TEVA is $8.27B

What is the all time high TTM gross profit for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high TTM gross profit is $11.91B

What is Teva Pharmaceutical Industries Limited TTM gross profit year-on-year change?

Over the past year, TEVA TTM gross profit has changed by +$200.45M (+2.48%)
On this page